NDC 62207-773 Ranitidine

Ranitidine

NDC Product Code 62207-773

NDC Code: 62207-773

Proprietary Name: Ranitidine What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.

Non-Proprietary Name: Ranitidine What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

Product Characteristics

Color(s):
BROWN (C48332)
Shape: ROUND (C48348)
Size(s):
9 MM
Imprint(s):
150;G
Score: 1

NDC Code Structure

  • 62207 - Granules India Ltd
    • 62207-773 - Ranitidine

NDC 62207-773-36

Package Description: 5 BAG in 1 CARTON > 10000 TABLET in 1 BAG (62207-773-32)

NDC 62207-773-41

Package Description: 1 BOTTLE in 1 CARTON > 24 TABLET in 1 BOTTLE

NDC 62207-773-47

Package Description: 1 BOTTLE in 1 CARTON > 500 TABLET in 1 BOTTLE

NDC 62207-773-58

Package Description: 2 BLISTER PACK in 1 CARTON > 10 TABLET in 1 BLISTER PACK

NDC Product Information

Ranitidine with NDC 62207-773 is a a human over the counter drug product labeled by Granules India Ltd. The generic name of Ranitidine is ranitidine. The product's dosage form is tablet and is administered via oral form.

Labeler Name: Granules India Ltd

Dosage Form: Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Ranitidine Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

  • RANITIDINE HYDROCHLORIDE 150 mg/1

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
  • CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
  • FERRIC OXIDE RED (UNII: 1K09F3G675)
  • MAGNESIUM STEARATE (UNII: 70097M6I30)
  • POLYETHYLENE GLYCOL (UNII: 3WJQ0SDW1A)
  • POLYVINYL ALCOHOL (UNII: 532B59J990)
  • TALC (UNII: 7SEV7J4R1U)
  • TITANIUM DIOXIDE (UNII: 15FIX9V2JP)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Oral - Administration to or by way of the mouth.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Granules India Ltd
Labeler Code: 62207
FDA Application Number: ANDA210243 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: ANDA - A product marketed under an approved Abbreviated New Drug Application. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 06-26-2019 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2020 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.

* Please review the disclaimer below.

Information for Patients

Ranitidine

Ranitidine is pronounced as (ra ni' ti deen)

Why is ranitidine medication prescribed?
Ranitidine is used to treat ulcers; gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and injury of the...
[Read More]
Ranitidine

Ranitidine is pronounced as (ra ni' ti deen)
Why is ranitidine medication prescribed?
Ranitidine is used to treat ulcers; gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and injury of the...
[Read More]

* Please review the disclaimer below.

Ranitidine Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Active Ingredient(S)

Ranitidine 150 mg

Purpose

Acid reducer

Use(S)

◾ relieves heartburn associated with acid indigestion and sour stomach


◾ prevents heartburn associated with acid indigestion and sour stomach brought on by eating or


   drinking certain foods and beverages

Warnings

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

Do Not Use

◾  if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.


     These may be signs of a serious condition. See your  doctor.


◾  with other acid reducers


◾  if you have kidney disease, except under the advice and supervision of a doctor

Ask A Doctor Before Use If

◾ had heartburn over 3 months. This may be a sign of a more serious condition.


◾ heartburn with lightheadedness, sweating or dizziness


◾ chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness


◾ frequent chest pain


◾ frequent wheezing, particularly with heartburn


◾ unexplained weight loss


◾ nausea or vomiting


◾ stomach pain

Stop Use And Ask Doctor If

◾ your heartburn continues or worsens


◾ you need to take this product for more than 14 days

Pregnancy/Breastfeeding

Ask a health professional before use.

Keep Out Of Reach Of Children

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

◾ adults and children 12 years and over:


   ◾ to


relieve symptoms, swallow 1 tablet with a glass of water


   ◾ to


prevent symptoms, swallow 1 tablet with a glass of water


​30 to 60 minutes before​ eating food or drinking beverages that cause heartburn


   ◾ can be used up to twice daily (do not take more than 2 tablets in 24 hours)


   ◾ do not chew tablet (for cool mint tablets only)


◾ children under 12 years: ask a doctor

Other Information

◾ do not use if printed foil under bottle cap is open or torn


◾ avoid excessive heat or humidity


◾ store at 20


0-25


0​C (68


0​-77


0​F)


◾ this product is sodium and sugar free

Inactive Ingredients

For 150 mg:croscarmellose sodium, iron oxide red, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol,talcum, titanium dioxide


For 150 mg cool mint:acacia, croscarmellose sodium, FD&C Blue No. 1,magnesium stearate, menthol, microcrystalline cellulose,polyethylene glycol, polyvinyl alcohol, talcum,


titanium dioxide

* Please review the disclaimer below.

Previous Code
62207-770
Next Code
62207-774